Medical Developments International Limited · ASX:MVP
Medical Developments International — Q3 FY24 Earnings Presentation
6 slides from Medical Developments International's earnings presentation, Apr 29, 2024
Slide 1: Q3 FY24 Quarterly Report
ASX:MVP Q3 FY24 QUARTERLY REPORT For personal use only 29 APRIL 2024
Slide 2: Important notice and disclaimer
Important notice and disclaimer This presentation contains summary information about Medical Developments International Limited (ACN 108340667) and its related bodies corporate (together, MVP) and MVP’s activities as at the date of this presentation. It is information given in summary form only and
Slide 3: Quarterly activity summary
Quarterly activity summary Good progress on margin and volume initiatives. US market entry paused to focus on underlying business in the near term FY24 strategic priorities Q3 progress • Business efficiency initiatives, which will deliver $2.6 million per annum earnings benefits, For personal use on
Slide 4: Cashflow
Cashflow Underlying operating cashflow improving Commentary $million YTD Current Operating cashflow for Q3 (9 months) Quarter • Underlying operating cashflows, excluding working capital changes, For personal use only improved Receipts from customers 26.4 7.1 • Working capital change of $2.5 million,
Slide 5: Closing remarks and outlook
Closing remarks and outlook Higher pricing and lower costs to drive strong improvement in underlying EBIT • Business efficiency and pricing initiatives delivering annualized benefits of $3.1 million implemented in Financial the quarter For personal use only performance • Underlying operating cashflo
Slide 6: Q3 FY24 Quarterly Report
ASX:MVP Q3 FY24 QUARTERLY REPORT For personal use only 29 APRIL 2024
Medical Developments International — Q3 FY24 Earnings Presentation on 6ix